Volume 18, Number 11—November 2012
Research
Risk for Travel-associated Legionnaires’ Disease, Europe, 2009
Julien Beauté
, Phillip Zucs, Birgitta de Jong, and for the European Legionnaires’ Disease Surveillance Network
, Phillip Zucs, Birgitta de Jong, and for the European Legionnaires’ Disease Surveillance Network
Table 2
Cases of travel-associated Legionnaires’ disease and risk per million nights in European domestic and nondomestic travelers, Europe, 2009*
| Destination | No. (% cases in domestic travelers) | No. nights spent by travelers, millions (% by domestic travelers) | TALD risk in cases/million nights |
|
|---|---|---|---|---|
| Domestic travelers | Nondomestic travelers | |||
| Italy | 209 (67) | 330 (64) | 0.66 | 0.58 |
| France | 137 (77) | 272 (72) | 0.54 | 0.41 |
| Spain | 98 (43) | 328 (45) | 0.28 | 0.31 |
| United Kingdom | 45 (98) | 228 (80) | 0.24 | 0.02 |
| Greece | 34 (0) | 58 (33) | 0.00 | 0.88 |
| Germany | 28 (0) | 296 (88) | 0.00 | 0.79 |
| Netherlands | 21 (86) | 79 (76) | 0.30 | 0.16 |
| Portugal | 20 (20) | 41 (47) | 0.21 | 0.73 |
| Austria | 20 (15) | 94 (33) | 0.10 | 0.27 |
| Other countries | 42 (14) | 314 (72) | 0.03 | 0.33 |
| Total | 607 (60) | 2,039 (66) | 0.27 | 0.36 |
*A case-patient could have a travel history involving >1 country. TALD, travel-associated Legionnaires’ disease.
Page created: October 16, 2012
Page updated: October 16, 2012
Page reviewed: October 16, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.